Lanier Biotherapeutics
Pre-clinicalLanier Biotherapeutics targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology.
Founded
2018
Focus
AntibodiesBiologics
About
Lanier Biotherapeutics targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology.
Funding History
1Total raised: $10M
Seed$10MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile